Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Brooklyn ImmunoTherapeutics (BTX)
NASDAQ:BTX
Brooklyn ImmunoTherapeutics (BTX) Financial Statements
0 Followers
Brooklyn ImmunoTherapeutics Financial Overview
| Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | - | - | - | - | - |
| EBIT | $ -3.38M | $ -9.37M | $ -8.44M | $ -86.04M | $ -10.01M |
| EBITDA | $ -3.23M | $ -9.24M | $ -8.32M | $ -85.91M | $ -9.90M |
| Net Income Common Stockholders | $ -3.41M | $ -9.38M | $ -8.47M | $ -86.06M | $ -10.09M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 8.41M | $ 16.98M | $ 19.41M | $ 23.50M | $ 24.38M |
| Total Assets | $ 26.90M | $ 35.38M | $ 32.43M | $ 39.39M | $ 64.71M |
| Total Debt | $ 1.17M | $ 2.29M | $ 2.72M | $ 3.23M | $ 3.36M |
| Net Debt | $ -7.24M | $ -14.69M | $ -16.68M | $ -20.27M | $ -21.02M |
| Total Liabilities | $ 12.12M | $ 18.07M | $ 25.93M | $ 26.35M | $ 29.53M |
| Stockholders Equity | $ 6.50M | $ 13.04M | $ 14.78M | $ 17.31M | $ 35.18M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -4.18M | $ -5.48M | $ -6.98M | $ -6.43M | $ -6.80M |
| Operating Cash Flow | $ -3.99M | $ -5.43M | $ -6.83M | $ -6.42M | $ -6.80M |
| Investing Cash Flow | $ -87.00K | $ -46.00K | $ -147.39K | $ -22.86M | $ -466.00 |
| Financing Cash Flow | $ -13.00K | $ 11.99M | $ -418.62K | $ 3.50M | $ 48.56M |
Brooklyn ImmunoTherapeutics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.